687 studies found for:    Open Studies | "Hematopoietic Stem Cells"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hematopoietic Stem Cells"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated Hematopoietic Stem Cell Transplant
Conditions: Hematopoietic Stem Cell Transplantation;   Stem Cell Transplantation, Hematopoietic;   Transplantation, Hematopoietic Stem Cell
Intervention:
2 Unknown  Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model
Conditions: Chronic Wounds;   Pressure Sores;   Hematopoietic Stem Cells;   Wound Healing
Intervention: Biological: Stem cell therapy
3 Unknown  Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: Busulfan
4 Recruiting Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias
Conditions: Leukemia, Myeloid, Acute;   Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intervention: Procedure: Haploidentical Stem Cell Transplantation
5 Recruiting T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Hematopoietic Stem Cell Transplant;   Poor Marrow Graft Function
Interventions: Procedure: Donor peripheral blood progenitor cells: stimulation, harvesting, isolation and T-cell depletion;   Device: CliniMACS Cell Selection System
6 Recruiting Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients
Conditions: Term and Preterm Neonates (24-41 Weeks Gestational Age);   Hematopoietic Stem Cell Transplant Recipient Children
Interventions: Other: Tubes fund recovery blood count;   Other: the rest of the blood test and stool sample
7 Unknown  Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation
Conditions: Neutropenia;   Hematopoietic Stem Cell Transplantation
Interventions: Drug: Piperacillin;   Drug: Piperacillin-tazobactam combination product
8 Recruiting Pilot Study Using Propranolol To Promote Prenylation Of The Gtpase Rap1b In Hematopoietic Stem Cell Transplant Recipients
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Other: Blood Draw
9 Recruiting Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Graft vs Host Disease;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Sitagliptin
10 Unknown  Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Conditions: Neutropenia;   Hematopoietic Stem Cell Transplantation;   Invasive Fungal Disease
Intervention: Drug: Micafungin
11 Recruiting Phase II Open Label Trial Of Tacrolimus/Methotrexate And Tocilizumab For The Prevention Of Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Condition: Hematopoietic Stem Cell Transplantation
Interventions: Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Tocilizumab
12 Recruiting Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Condition: Allogeneic Hematopoietic Stem Cell
Interventions: Biological: fecal microbiota transplantation (FMT);   Other: No fecal microbiota transplantation (FMT), routine management
13 Recruiting A Multi-Institutional Phase II Feasibility Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
Conditions: Neuroepithelial Tumor;   Solid Tumor;   Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Procedure: Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy;   Drug: Keratinocyte Growth Factor;   Drug: Alemtuzumab;   Drug: Thiotepa;   Drug: Etoposide;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Tacrolimus;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil
14 Recruiting Dose Finding Study of Vedolizumab for Graft-Versus-Host Disease (GvHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Condition: Allogeneic Hematopoietic Stem Cell Transplantation
Intervention: Drug: Vedolizumab
15 Recruiting Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)
Condition: Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Interventions: Biological: Recipients;   Biological: Donors
16 Unknown  Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents
Conditions: Haploidentical Hematopoietic Stem Cell Transplantation;   Malignant Disease;   Non-malignant Disease
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: anti-thymocyte globulin;   Biological: filgrastim;   Radiation: Total body irradiation;   Procedure: TCRαβ-depleted hematopoietic cell transplantation;   Device: CliniMACS
17 Not yet recruiting Meloxicam vs Placebo for Mobilization
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Lymphoma;   Multiple Myeloma;   Hematopoietic Stem Cells
Interventions: Drug: GCSF;   Drug: meloxicam;   Drug: Placebo
18 Recruiting Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers
Conditions: Bone Marrow Transplantation;   Hematopoietic Stem Cells;   Multiple Myeloma;   Lymphoma
Interventions: Drug: Neupogen;   Procedure: Hyperbaric oxygen therapy;   Drug: Plerixafor
19 Recruiting Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Other: Data Collection
20 Not yet recruiting Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
Conditions: Acute Myeloid Leukemia;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Sorafenib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years